Results 191 to 200 of about 36,234 (283)

Reversible cerebral vasoconstriction syndrome: A narrative review

open access: yesHeadache: The Journal of Head and Face Pain, Volume 66, Issue 5, Page 1162-1180, May 2026.
Abstract Objectives/Background This review summarizes current insights into Reversible cerebral vasoconstriction syndrome (RCVS) diagnosis, management, and outcomes. RCVS is a cerebrovascular disorder characterized by recurrent thunderclap headaches and transient segmental vasoconstriction of cerebral arteries, typically resolving within 3 months ...
Ícaro Araújo de Sousa   +7 more
wiley   +1 more source

Single‐Cell Analysis of Preeclamptic Cord Blood Mononuclear Cells Revealed Activation of Heme‐Associated Signalling Pathways

open access: yesJournal of Cellular and Molecular Medicine, Volume 30, Issue 9, May 2026.
ABSTRACT Preeclampsia is a severe gestational complication whose molecular pathogenesis remains poorly understood despite extensive research. It is now recognized that both maternal and fetal cells contribute to disease progression. Notably, single‐cell RNA sequencing of cord blood cells from preeclamptic pregnancies has not been previously ...
Polina Vishnyakova   +14 more
wiley   +1 more source

Increased levels of two distinct elastase-like hydrolases in plasma during septicemia [PDF]

open access: yes, 1983
Duswald, Karl-Heimo   +4 more
core   +1 more source

Association of glucagon‐like peptide‐1 receptor agonist use with clinical outcomes in patients with rheumatoid arthritis and type 2 diabetes

open access: yesJournal of Diabetes Investigation, Volume 17, Issue 5, Page 766-780, May 2026.
This TriNetX (US, 2016–2023) study compared clinical outcomes in patients with rheumatoid arthritis and type 2 diabetes treated with GLP‐1 receptor agonists vs DPP4 inhibitors. ABSTRACT Objectives To evaluate whether glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) are associated with improved survival and renal outcomes in patients with ...
Yu‐Ting Yu   +4 more
wiley   +1 more source

The Risk Factors for Placental Abruption in Preeclamptic Pregnancies: A Retrospective Case–Control Study

open access: yesJournal of Obstetrics and Gynaecology Research, Volume 52, Issue 5, May 2026.
ABSTRACT Aim Preeclampsia poses a high‐risk factor for placental abruption. The precise understanding of the accompanying symptoms and disease phenotype of preeclampsia, in order to promptly identify the occurrence of placental abruption in preeclamptic women, remains unclear.
Kechen Li   +6 more
wiley   +1 more source

Postpartum Ischemic Stroke As the First Manifestation of Late-Onset Preeclampsia: A Case Report. [PDF]

open access: yesCureus
Benaini I   +6 more
europepmc   +1 more source

Identification and Validation of DLD as a Cuproptosis‐Associated Biomarker in Preeclampsia

open access: yesThe FASEB Journal, Volume 40, Issue 8, 30 April 2026.
DLD is identified as a preeclampsia‐associated cuproptosis hub gene by bioinformatics. DLD overexpression inhibits trophoblast proliferation, invasion, and migration, disrupts TCA cycle metabolism, and alters mitochondrial ultrastructure. These findings reveal that DLD may contribute to preeclampsia pathogenesis through cuproptosis.
Shuisen Zheng   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy